MTEM Stock Price History and Quote Analysis: Insights for Investors
Molecular Templates, Inc.
Stock Price Today
Molecular Templates, Inc. (MTEM) stock surged +4.29%, trading at $1.46 on NASDAQ, up from the previous close of $1.40. The stock opened at $1.41, fluctuating between $1.40 and $1.47 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that is in Phase I clinical trial for the treatment of HER2-positive cancers; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory myeloma patients; and MT-6402 in that is in Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients. Its pipeline of ETBs in development for other targets, including CTLA-4, TIGIT, TROP2, BCMA, SLAMF-7, and CD45. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.
Company Information
| Employees | 62 |
| Beta | 1.155 |
| Sales or Revenue | $57.31M |
| 5Y Sales Change% | 2.45% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Molecular Templates, Inc. (NASDAQ: MTEM) stock price is $1.46 in the last trading session. During the trading session, MTEM stock reached the peak price of $1.47 while $1.40 was the lowest point it dropped to. The percentage change in MTEM stock occurred in the recent session was 4.29% while the dollar amount for the price change in MTEM stock was $0.06.
The NASDAQ listed MTEM is part of Biotechnology industry that operates in the broader Healthcare sector. Molecular Templates, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Erin Willert Ph.D.
Executive Vice President of R&D
Dr. Jen-Sing Liu Ph.D.
Executive Vice President of Manufacturing
Dr. Eric E. Poma Ph.D.
Chief Executive Officer, Chief Scientific Officer & Director
Mr. Michael Dowd
Senior Vice President of Project & Alliance Management
Dr. Grace Kim
Chief Strategy Officer & Head of IR
Dr. Joseph Phillips Ph.D.
Senior Vice President & Head of CMC Devel.
Dr. Jack Higgins Ph.D.
Executive Vice President of Operations & Head of Manufacturing
Mr. Kurt Elster
Executive Vice President of Corporation Devel.
Ms. Jason S Kim
Pres, Chief Financial Officer, Treasurer & Principal Accounting Officer
Dr. Gabriela Gruia M.D.
Interim Chief Medical Officer & Director
Ms. Kristen Quigley B.A.
Chief Operating Officer
Dr. Roger J. Waltzman M.B.A., M.D.
Chief Medical Officer
Ms. Megan C. Filoon
Gen. Counsel & Sec.
Mr. Ryan Hawkins
Senior Vice President & Head of Manufacturing
Mr. Sean McLennan
Senior Vice President of Fin., Controller, Interim Principal Accounting Officer, Interim Chief Financial Officer & Treasurer
MTEM's closing price is 46.01% higher than its 52-week low of $1.00 where as its distance from 52-week high of $6.90 is -78.84%.
Number of MTEM employees currently stands at 62.
Official Website of MTEM is: https://www.mtem.com
MTEM could be contacted at phone 512 869 1555 and can also be accessed through its website. MTEM operates from 9301 Amberglen Boulevard, Austin, TX 78729, United States.
MTEM stock volume for the day was 50.37K shares. The average number of MTEM shares traded daily for last 3 months was 27.69K.
The market value of MTEM currently stands at $9.61M with its latest stock price at $1.46 and 6.58M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com